Adding clinical variables to the standard Syntax score boosts the ability to stratify risk for long-term adverse clinical outcomes, particularly 5-year mortality, in patients receiving drug-eluting ...

In patients with moderate- and high-risk acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI), the Syntax score predicts 1-year ischemic outcomes including mortality, ...

Compared with the classic SYNTAX score, the functional SYNTAX score decreased the number of higher-risk patients and better discriminated risk for adverse events in patients with multivessel coronary ...

Real-world registry data show that the SYNTAX score II 2020 (SSII-2020) reliably predicts mortality but not major adverse cardiovascular events (MACE) 5 years after stenting and coronary bypass ...

The SYNTAX score is an anatomical-based tool that has quickly become established for long-term risk prediction after percutaneous coronary intervention (PCI). Since publication of the SYNTAX trial, Dr ...

Please provide your email address to receive an email when new articles are posted on . At 5 years, elevated rates of major CV events were found in patients with diabetes and stable ischemic heart ...

September 13, 2010 (Geneva, Switzerland) — Three-year results for the landmark SYNTAX trial are bringing some clarity to a finding just hinted at--then strenuously debated--at the two-year mark: ...

ORLANDO – November 4, 2021 – The primary results of the Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 trial found that percutaneous coronary intervention (PCI) guided ...